Shoulder Innovations (SI) CCO Jonathan Osborne reports stock and option stakes
Rhea-AI Filing Summary
SHOULDER INNOVATIONS, INC. reports that Chief Commercial Officer Jonathan E. Osborne beneficially owns 60,355 shares of Common Stock directly. He also holds stock options over 24,870 shares at an exercise price of $2.48 expiring on July 12, 2034, 19,423 shares at $2.86 expiring on April 23, 2035, and 126,357 shares at $14.16 expiring on January 30, 2033. Footnotes describe graded vesting schedules, including options that vested one-fourth initially with the remainder vesting in 12 equal quarterly increments, and another grant vesting one-fourth annually on March 1 starting in 2027.
Positive
- None.
Negative
- None.
Insider Trade Summary
4 transactions reported
Mixed
4 txns
Insider
Osborne Jonathan E.
Role
Chief Commercial Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Option F1 | -- | -- | -- |
| holding | Stock Option F2 | -- | -- | -- |
| holding | Stock Option F3 | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Option — 170,650 shares (Direct);
Common Stock — 60,355 shares (Direct)
Footnotes (3)
- F1. The stock option vested as to one-fourth of the underlying shares on September 7, 2024, and the remaining shares vest in 12 equal increments on the last day of each fiscal quarter beginning on September 30, 2024.
- F2. The stock option vested as to one-fourth of the underlying shares on April 1, 2026, and the remaining shares vest in 12 equal increments on the last day of each fiscal quarter beginning on June 30, 2026.
- F3. The stock option vests as to one-fourth of the underlying shares on March 1st each year, beginning on March 1, 2027.
Key Figures
Direct common shares owned: 60,355 shares
Option underlying shares @ $2.48: 24,870 shares
Option underlying shares @ $2.86: 19,423 shares
+1 more
4 metrics
Direct common shares owned
60,355 shares
Direct beneficial ownership of Common Stock reported by Jonathan E. Osborne
Option underlying shares @ $2.48
24,870 shares
Stock option over Common Stock at $2.48, expiring July 12, 2034
Option underlying shares @ $2.86
19,423 shares
Stock option over Common Stock at $2.86, expiring April 23, 2035
Option underlying shares @ $14.16
126,357 shares
Stock option over Common Stock at $14.16, expiring January 30, 2033
Key Terms
beneficially owns, stock option, underlying shares, vests as to one-fourth
4 terms
beneficially owns financial
"reports that Chief Commercial Officer Jonathan E. Osborne beneficially owns 60,355 shares"
Beneficially owns means a person or entity enjoys the economic benefits and control of a security even if the legal title or registration is held in another name. Think of it like having the keys and profits from a car that is registered to a friend: you use it, benefit from it, and make decisions about it even though the official paperwork lists someone else. For investors, this matters because it reveals who truly controls shares, affects voting power, potential conflicts of interest, and regulatory disclosure obligations.
stock option financial
"The stock option vested as to one-fourth of the underlying shares on September 7, 2024"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
vests as to one-fourth financial
"The stock option vests as to one-fourth of the underlying shares on March 1st each year"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider position did SI’s Jonathan E. Osborne report on Form 3?
Jonathan E. Osborne, Chief Commercial Officer of SHOULDER INNOVATIONS, INC. (SI), reported direct beneficial ownership of 60,355 shares of Common Stock, plus several stock option grants over additional shares with specified exercise prices and expiration dates.
What is the largest stock option grant reported by Jonathan E. Osborne in SI?
The largest grant is a stock option over 126,357 SI common shares at an exercise price of $14.16 per share, expiring on January 30, 2033. Footnotes state it vests one-fourth of the underlying shares each March 1, beginning in 2027.
How do Osborne’s SI stock options vest according to the Form 3 footnotes?
One option vested one-fourth on September 7, 2024, with remaining shares vesting in 12 quarterly increments from September 30, 2024. Another vested one-fourth on April 1, 2026, with similar quarterly vesting, while a third vests one-fourth annually each March 1 starting 2027.